Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation ...
Zacks Investment Research on MSN
JNJ gets EU nod for expanded use of Akeega in prostate cancer
J&J JNJ announced that the European Commission has approved its precision therapy, Akeega (niraparib and abiraterone acetate dual action tablet), for expanded use in prostate cancer. The regulatory ...
Prostate cancer is the most common cancer in men throughout the United States. Most men do not realize they have cancer due ...
MedPage Today on MSN
Bubbles of prostate cancer info; cancer drug tops moneymakers; small kidney tumors
News, features, and commentary about cancer-related issues ...
A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...
A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...
Manufacturing optimization is projected to expand batch output by ~50%, improving supply reliability and supporting higher-throughput PSMA PET imaging services. Increased radioactivity extends shelf ...
Researchers found men who ejaculated more often had fewer prostate cancer diagnoses, pointing to a possible biological ...
Longtime friends and allies of former President Joe Biden are worried about the toll cancer treatment is taking on the 83-year-old, despite aides expressing optimism, those close to the former ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results